Remarkably, 6 showed a significantly improved anti-tumorefficacy in a Kasumi-1 acute myeloid leukemia (AML) cell line, whichcritically depends on both BCL-xL and BCL-2 for survival. Here, BCL2L1 is linked to acute myeloid leukemia.